Role of Baseline Antral Follicle Count and Anti-Mullerian Hormone in Prediction of Cumulative Live Birth in the First In Vitro Fertilisation Cycle: A Retrospective Cohort Analysis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Li, Hang Wun Raymond ^a   Lee, Vivian Chi Yan ^a   Lau, Estella Yee Lan ^a   Yeung, William Shu Biu ^a   Ho, Pak Chung ^a   Ng, Ernest Hung Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BASELINE ANTRAL FOLLICLE COUNT; BIRTH RATE; CELL COUNT; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; LIVE BIRTH; MATERNAL AGE; OVARY FOLLICLE CELL; OVULATION INDUCTION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REPRODUCTIVE SUCCESS; RETROSPECTIVE STUDY; STIMULUS RESPONSE; BLOOD; COHORT ANALYSIS; CYTOLOGY; OVARY FOLLICLE; PREGNANCY; PROCEDURES;

ADULT; ANTI-MULLERIAN HORMONE; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; HUMANS; LIVE BIRTH; OVARIAN FOLLICLE; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 84876540514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061095     Document Type: Article

References (24)

1. Nelson SM, Yates RW, Fleming R, (2007) Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy. Hum Reprod 22(9): 2414-2421.
2. Nelson SM, Anderson RA, Broekmans FJ, Raine-Fenning N, Fleming R, et al. (2012) Anti-Mullerian hormone: clairvoyance or crystal clear? Hum Reprod 27(3): 631-636.
3. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB, (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12: 685-718.
4. Broer SL, Mol BWJ, Hendriks D, Broekmans FJM, (2009) The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 91(3): 705-714.
5. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, et al. (2011) AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update 17(1): 46-54.
6. Broer SL, Mol B, Dolleman M, Fauser BC, Broekmans FJ, (2010) The role of anti-Mullerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 22: 193-201.
7. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, et al. (1996) Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81: 571-576.
8. Hensen KR, Hodnett GM, Knowlton N, Craig LB, (2011) Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 95(1): 170-175.
9. Anderson RA, Nelson SM, Wallace WHB, (2012) Measuring anti-Mullerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas 71(1): 28-33.
10. Kini S, Li HWR, Morrell D, Pickering S, Thong KJ, (2010) Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization. J Assist Reprod Genet 27(8): 449-456.
11. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R, et al. (2003) Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 18: 328-332.
12. La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, et al. (2004) Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 19: 2738-2741.
13. Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, et al. (2010) Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Hum Reprod 25: 2597-2604.
14. Veeck LL (1999) An atlas of human gametes and conceptuses. New York: The Parthenon Publishing Group.
15. Yeung WSB, Li RHW, Cheung TM, Ng EHY, Lau EYL, et al. (2009) Frozen-thawed embryo transfer cycles. Hong Kong Med J 15(6): 420-426.
16. Van Disseldorp J, Lambalk CB, Kwee J, Looman CW, Eijkemans MJ, et al. (2010) Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod 25: 221-227.
17. Borini A, Cattoli M, Bulletti C, Goticchio G, (2008) Clinical efficiency of oocyte and embryo cryopreservation. Ann N Y Acad Sci 1127: 49-58.
18. Cai QF, Wan F, Huang R, Zhang HW, (2011) Factors predicting the cumulative outcome of IVF/ICSI treatment: a multivariable analysis of 2450 patients. Hum Reprod 26(9): 2532-2540.
19. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, et al. (2011) Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 26(7): 1768-1774.
20. Mitwally MF, Bhakoo HS, Crickard K, Sullivan MW, Batt RE, et al. (2006) Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 86: 588-596.
21. Ng EHY, (2009) Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment. Gynecol Endocrinol 25(1): 2-7.
22. Lie Fong S, Baart EB, Martini E, Schipper I, Visser JA, et al. (2008) Themmen AP, de Jong FH, Fauser BJ, Laven JS. Anti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online 16(5): 664-670.
23. Plante BJ, Beamon C, Schmitt CL, Moldenhauer JS, Steiner AZ, (2010) Maternal antimullerian hormone levels do not predict fetal aneuploidy. J Assist Reprod Genet 27: 409-414.
24. Kline JK, Kinney AM, Levin B, Kelly AC, Ferin M, et al. (2011) Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis. Hum Reprod 26(6): 1537-1550.